{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:52:14Z","timestamp":1792090334210,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P35241"],"award-info":[{"award-number":["P35241"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.apsb.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:20:11Z","timestamp":1773458411000},"page":"3746-3763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Primulagenin A is a potent inverse agonist of the nuclear receptor RAR-related orphan receptor gamma (ROR\u03b3)"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3093-4176","authenticated-orcid":false,"given":"Patrik F.","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3922-6333","authenticated-orcid":false,"given":"Alexander F.","family":"Perhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Preglej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0101-3107","authenticated-orcid":false,"given":"Lina","family":"Breit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus G.","family":"Schmetterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0305-9270","authenticated-orcid":false,"given":"Ulrike","family":"Grienke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8975-3222","authenticated-orcid":false,"given":"Jasmin","family":"Jannesch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Rochel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2667-5877","authenticated-orcid":false,"given":"Johannes","family":"Kirchmair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9608-0057","authenticated-orcid":false,"given":"Nina","family":"Sch\u00fctzenmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6581-0774","authenticated-orcid":false,"given":"Judith M.","family":"Rollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9261-5293","authenticated-orcid":false,"given":"Verena M.","family":"Dirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.03.003_bib1","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1021\/np200391c","article-title":"The relevance of higher plants in lead compound discovery programs","volume":"74","author":"Kinghorn","year":"2011","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2026.03.003_bib2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2026.03.003_bib3","author":"David"},{"key":"10.1016\/j.apsb.2026.03.003_bib4","author":"Murphy"},{"key":"10.1016\/j.apsb.2026.03.003_bib5","author":"Sadiq"},{"key":"10.1016\/j.apsb.2026.03.003_bib6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2007.08.021","article-title":"Molecular understanding and modern application of traditional medicines: triumphs and trials","volume":"130","author":"Corson","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.03.003_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fphar.2019.00743","article-title":"Systems pharmacology for investigation of the mechanisms of action of traditional Chinese medicine in drug discovery","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.003_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5483\/BMBRep.2022.55.9.102","article-title":"Systems pharmacology approaches in herbal medicine research: a brief review","volume":"55","author":"Lee","year":"2022","journal-title":"BMB Rep"},{"key":"10.1016\/j.apsb.2026.03.003_bib10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-2007-985964","article-title":"Thymian und Primelwurzel-ein starkes Doppel gegen akute Bronchitiden","volume":"56","author":"Gr\u00fcnwald","year":"2007","journal-title":"Erfahrungsheilkunde"},{"key":"10.1016\/j.apsb.2026.03.003_bib11","first-page":"669","article-title":"Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis. A double-blind, randomized, placebo-controlled clinical trial","volume":"55","author":"Gruenwald","year":"2005","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.apsb.2026.03.003_bib12","first-page":"574","volume":"56","author":"Gruenwald","year":"2006","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.apsb.2026.03.003_bib13","first-page":"607","article-title":"Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial","volume":"57","author":"Kemmerich","year":"2007","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.apsb.2026.03.003_bib14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1101\/gad.8.5.538","article-title":"Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors","volume":"8","author":"Giguere","year":"1994","journal-title":"Genes Dev"},{"key":"10.1016\/j.apsb.2026.03.003_bib15","first-page":"757","article-title":"RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers","volume":"8","author":"Carlberg","year":"1994","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.apsb.2026.03.003_bib16","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1006\/bbrc.1994.2902","article-title":"ROR gamma: the third member of ROR\/RZR orphan receptor subfamily that is highly expressed in skeletal muscle","volume":"205","author":"Hirose","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2026.03.003_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/MOL.0b013e328338ca18","article-title":"Ligand regulation of retinoic acid receptor-related orphan receptors: implications for development of novel therapeutics","volume":"21","author":"Solt","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.apsb.2026.03.003_bib18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.03.003_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.03.003_bib20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature09978","article-title":"Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity","volume":"472","author":"Huh","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.03.003_bib21","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/eji.201242740","article-title":"Small molecule inhibitors of RORgammat: targeting Th17 cells and other applications","volume":"42","author":"Huh","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.apsb.2026.03.003_bib22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-pharmtox-010919-023711","article-title":"(Inverse) agonists of retinoic acid-related orphan receptor gamma: regulation of immune responses, inflammation, and autoimmune disease","volume":"60","author":"Jetten","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2026.03.003_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106324","article-title":"Nuclear receptor RORgamma inverse agonists\/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancy","volume":"182","author":"Zou","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.03.003_bib24","doi-asserted-by":"crossref","first-page":"11618","DOI":"10.1074\/jbc.M117.789024","article-title":"Structural studies unravel the active conformation of apo RORgammat nuclear receptor and a common inverse agonism of two diverse classes of RORgammat inhibitors","volume":"292","author":"Li","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.03.003_bib25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/cb200496y","article-title":"Identification of SR2211: a potent synthetic RORgamma-selective modulator","volume":"7","author":"Kumar","year":"2012","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.apsb.2026.03.003_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1039\/D0NP00047G","article-title":"Natural products as modulators of retinoic acid receptor-related orphan receptors (RORs)","volume":"38","author":"Ladurner","year":"2021","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.apsb.2026.03.003_bib27","series-title":"Wichtl \u2013 teedrogen und Phytopharmaka. Ein Handbuch f\u00fcr die Praxis","first-page":"519","article-title":"Primelwurzel (Primulae radix)","author":"Volk","year":"2016"},{"key":"10.1016\/j.apsb.2026.03.003_bib28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0031-9422(75)85071-0","article-title":"Protoprimulagenin a Als Aglykon des Hauptsaponins von Primula elatior","volume":"14","author":"Tschesche","year":"1975","journal-title":"Phytochemistry"},{"key":"10.1016\/j.apsb.2026.03.003_bib29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0042-6822(73)90341-3","article-title":"A new technique for the assay of infectivity of human adenovirus 5 DNA","volume":"52","author":"Graham","year":"1973","journal-title":"Virology"},{"key":"10.1016\/j.apsb.2026.03.003_bib30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0031-9422(89)80123-2","article-title":"Saponins in Cyclamen species: configuration of cyclamiretin C and structure of isocyclamin","volume":"28","author":"Reznicek","year":"1989","journal-title":"Phytochemistry"},{"key":"10.1016\/j.apsb.2026.03.003_bib31","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/om100106e","article-title":"NMR chemical shifts of trace impurities: common laboratory solvents, organics, and gases in deuterated solvents relevant to the organometallic chemist","volume":"29","author":"Fulmer","year":"2010","journal-title":"Organometallics"},{"key":"10.1016\/j.apsb.2026.03.003_bib32","series-title":"Medical device guidelines and regulations handbook","first-page":"163","article-title":"ISO 10993: biological evaluation of medical devices","author":"Thangaraju","year":"2022"},{"key":"10.1016\/j.apsb.2026.03.003_bib33","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.03.003_bib34","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.03.003_bib35","series-title":"Schr\u00f6dinger release 2023-4: glide","year":"2023"},{"key":"10.1016\/j.apsb.2026.03.003_bib36","series-title":"Schr\u00f6dinger release 2023-4","year":"2023"},{"key":"10.1016\/j.apsb.2026.03.003_bib37","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","article-title":"Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution","volume":"24","author":"Greenwood","year":"2010","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.apsb.2026.03.003_bib38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK(a) prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.apsb.2026.03.003_bib39","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J Chem Theor Comput"},{"key":"10.1016\/j.apsb.2026.03.003_bib40","series-title":"Schr\u00f6dinger release 2023-4","year":"2023"},{"key":"10.1016\/j.apsb.2026.03.003_bib44","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.3390\/biomedicines10092076","article-title":"Identification of the natural steroid sapogenin diosgenin as a direct dual-specific RORalpha\/gamma inverse agonist","volume":"10","author":"Schwarz","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.apsb.2026.03.003_bib45","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2013\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.apsb.2026.03.003_bib46","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.celrep.2018.02.044","article-title":"IL-23 and IL-1beta drive human Th17 cell differentiation and metabolic reprogramming in absence of CD28 costimulation","volume":"22","author":"Revu","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.03.003_bib47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41467-020-20385-9","article-title":"Genetic and pharmacological inhibition of the nuclear receptor RORalpha regulates TH17 driven inflammatory disorders","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.03.003_bib48","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3390\/biom13101465","article-title":"Harnessing oleanolic acid and its derivatives as modulators of metabolic nuclear receptors","volume":"13","author":"Radwan","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.apsb.2026.03.003_bib49","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.3390\/biomedicines11102845","article-title":"Overview of ursolic acid potential for the treatment of metabolic disorders, autoimmune diseases, and cancers via nuclear receptor pathways","volume":"11","author":"Kadasah","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.apsb.2026.03.003_bib50","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/08820139.2019.1698599","article-title":"The inhibitory effects of pentacyclic triterpenes from loquat leaf against Th17 differentiation","volume":"49","author":"Zhou","year":"2020","journal-title":"Immunol Investig"},{"key":"10.1016\/j.apsb.2026.03.003_bib51","doi-asserted-by":"crossref","first-page":"22707","DOI":"10.1074\/jbc.C111.250407","article-title":"Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma t protein","volume":"286","author":"Xu","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.03.003_bib52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/adt.2011.0390","article-title":"Thermal denaturation assays in chemical biology","volume":"10","author":"Senisterra","year":"2012","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.apsb.2026.03.003_bib53","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/mol.109.060905","article-title":"The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha\/gamma inverse agonist","volume":"77","author":"Kumar","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.003_bib54","doi-asserted-by":"crossref","first-page":"eabn7774","DOI":"10.1126\/sciadv.abn7774","article-title":"RORgammat expression in mature TH17 cells safeguards their lineage specification by inhibiting conversion to TH2 cells","volume":"8","author":"Chi","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2026.03.003_bib55","series-title":"Glenmark pharmaceuticals SA, assignee. Treatment of respiratory disorders using ROR-gamma inhibitors","author":"Khairatkar-Joshi","year":"2018"},{"key":"10.1016\/j.apsb.2026.03.003_bib56","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jff.2017.11.032","article-title":"The gastrointestinal behavior of saponins and its significance for their bioavailability and bioactivities","volume":"40","author":"Navarro del Hierro","year":"2018","journal-title":"J Funct Foods"},{"key":"10.1016\/j.apsb.2026.03.003_bib57","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.4049\/jimmunol.1600737","article-title":"Ex-Th17 (Nonclassical Th1) cells are functionally distinct from classical Th1 and Th17 cells and are not constrained by regulatory T cells","volume":"198","author":"Basdeo","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.03.003_bib58","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nri.2017.50","article-title":"The dichotomous nature of T helper 17 cells","volume":"17","author":"Stockinger","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.03.003_bib59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/bdd.530","article-title":"Dose\u2013linear pharmacokinetics of oleanolic acid after intravenous and oral administration in rats","volume":"28","author":"Jeong","year":"2007","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.apsb.2026.03.003_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1308749","article-title":"Development and evaluation of oleanolic acid dosage forms and its derivatives","volume":"2020","author":"Feng","year":"2020","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.apsb.2026.03.003_bib61","first-page":"901","article-title":"High incidence of T-cell lymphomas in mice deficient in the retinoid-related orphan receptor RORgamma","volume":"62","author":"Ueda","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2026.03.003_bib62","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.autrev.2016.07.036","article-title":"Retinoid-related orphan receptor gamma (RORgamma) adult induced knockout mice develop lymphoblastic lymphoma","volume":"15","author":"Liljevald","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.apsb.2026.03.003_bib63","first-page":"93","article-title":"Thymic lymphomas in a 6-month rasH2-Tg mouse carcinogenicity study with the RORgammat inverse agonist, BMS-986251","volume":"183","author":"Haggerty","year":"2021","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2026.03.003_bib64","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/cpdd.1243","article-title":"Safety, tolerability, and pharmacokinetics of IMU-935, a novel inverse agonist of retinoic acid receptor-related orphan nuclear receptor gammat: results from a double-blind, placebo-controlled, first-in-human phase 1 study","volume":"12","author":"Polasek","year":"2023","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.apsb.2026.03.003_bib65","series-title":"Proceedings of the 2nd conference on molecular mechanisms of inflammation","article-title":"IMU-935: orally available small molecule inhibitor of IL-17 with unique molecular profile for the treatment of autoimmune diseases","author":"Kohlhof","year":"2019"},{"key":"10.1016\/j.apsb.2026.03.003_bib66","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1080\/17460441.2021.1948833","article-title":"Retinoic acid-related orphan receptor gamma T (RORgammat) inverse agonists\/antagonists for the treatment of inflammatory diseases\u2014where are we presently?.","volume":"16","author":"Gege","year":"2021","journal-title":"Expet Opin Drug Discov"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221138352600153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221138352600153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:04:36Z","timestamp":1783022676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221138352600153X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S221138352600153X"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.03.003","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.04.01.646598","asserted-by":"object"}]},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primulagenin A is a potent inverse agonist of the nuclear receptor RAR-related orphan receptor gamma (ROR\u03b3)","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}